Edition:
United States

Axovant Sciences Ltd (AXON.OQ)

AXON.OQ on NASDAQ Stock Exchange Global Select Market

1.96USD
1:59pm EST
Change (% chg)

$-0.12 (-5.77%)
Prev Close
$2.08
Open
$2.08
Day's High
$2.11
Day's Low
$1.94
Volume
65,770
Avg. Vol
149,133
52-wk High
$6.58
52-wk Low
$1.02

Chart for

About

Axovant Sciences Ltd. is a clinical-stage biopharmaceutical company. The Company is focused on acquiring, developing and commercializing therapeutics for the treatment of dementia, including Alzheimer's disease and Lewy body dementia. The Company intends to develop a pipeline of product candidates to address the cognitive,... (more)

Overall

Beta: --
Market Cap(Mil.): $758.06
Shares Outstanding(Mil.): 107.53
Dividend: --
Yield (%): --

Financials

  AXON.OQ Industry Sector
P/E (TTM): -- 85.49 33.64
EPS (TTM): -2.09 -- --
ROI: -85.17 -0.29 14.22
ROE: -95.04 0.40 15.99

Earnings vs. Estimates